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The function of pluripotency genes in differentiation is a matter of investigation. We report here that Nanog and Oct4 are
reexpressed in two mouse embryonic stem cell (mESC) lines following exposure to the differentiating agent DETA/NO. Both cell
lines express a battery of both endoderm and mesoderm markers following induction of differentiation with DETA/NO-based
protocols. Confocal analysis of cells undergoing directed differentiation shows that the majority of cells expressing Nanog express
also endoderm genes such as Gata4 and FoxA2 (75.4% and 96.2%, resp.). Simultaneously, mRNA of mesodermal markers Flk1
and Mef2c are also regulated by the treatment. Acetylated histone H3 occupancy at the promoter of Nanog is involved in the
process of reexpression. Furthermore, Nanog binding to the promoter of Brachyury leads to repression of this gene, thus disrupting
mesendoderm transition.
1. Introduction
Embryonic stem cells (ESCs) self-renew continuously and
differentiate into any cell type. Mouse ESCs self-renewal
is at least in part controlled by extracellular signals such
as leukemia inhibitory factor (LIF), which maintain the
undifferentiated state through activation of Stat3 pathway [1].
Studies over the past few years have revealed the role played
by transcription factor networks and epigenetic processes in
the maintenance of ESC pluripotency [2]. Current evidence
suggests that ESC pluripotency is orchestrated by the expres-
sion of Nanog, Oct4, Sox2, and Ronin genes [2–7]. Nanog
plays a prominent role in the maintenance of pluripotent
epiblast and in the prevention of differentiation towards
primitive endoderm of cells of inner mass during embryonic
development [4]. On the other hand, heterogeneous expres-
sion of Nanog has been documented in ESCs and fluctuations
inNanog expression in cells are being suggested to provide an
opportunity for differentiation [8–10]. Furthermore, Nanog
overexpression blocks ectoderm and definitive endoderm
(DE) differentiation in both human ESCs and mouse epiblast
cells [11]. Additional roles of these genes might be considered
since they are also expressed in DE cells [12–15].
Changes in chromatin structure also play a role in the
biology of stem cells [16–18]. Through epigenetic processes,
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the pluripotent epigenome keeps the chromatin structure
open to allow for rapid genetic regulation [19]. Nitric oxide
(NO) is a signallingmolecule that plays a role in developmen-
tal processes, but themechanisms involved are still amatter of
study [20–22]. In this regard, differentiation of ESC into cells
derived from the three embryonic germ layers following in
vitro exposure to NO has been reported [23–26]. In addition,
global changes in histone acetylation during induction of
endodermic [23] andmesodermic [27] differentiation by NO
have been described. These findings highlight the relevance
of combined actions of signalling pathways and epigenetic
rearrangements during ESC differentiation. In this study,
we report that downregulation of stemness transcription
factors during NO-induced differentiation is transient and
that occupancy of promoter regions of differentiation genes
such as Brachyury by these factors plays a role in the control
of lineage specification.
2. Materials and Methods
2.1. Cell Culture, DETA/NO Treatment, Definitive Endoderm
Differentiation, Transfection, and Sorting. D3mESCs (ES-D3
ATCC CRL-1934) were cultured at 37∘C with 5% CO
2
. Cells
were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) (Gibco, Paisley, UK), supplemented with 15%
heat-inactivated fetal bovine serum (FBS) (Hyclone, Logan
Utah, USA), 0.5mM 𝛽-mercaptoethanol (Gibco), 2mM L-
glutamine (Gibco), 0.1mMMEMNon-Essential amino acids
(Gibco), 5000U/mL penicillin/streptomycin (Gibco), and
1000U/mL LIF (ESGRO, Chemicon, Billerica, MA, USA).
When appropriate, cells were cultured for 3 days either in the
presence or absence of LIF. Treatment with 1mM diethylene-
triamine/nitric oxide adduct (DETA/NO) (Sigma-Aldrich, St.
Louis MO, USA) was carried out for 19 h in cultured medium
containing 15% FBS and LIF as required. For immunochip
analysis, cells were exposed to 0.5mM DETA/NO instead.
This concentration provoked lower levels of cell death than
1mM, thus allowing obtaining sufficient amounts of nuclear
protein to perform the chromatin immunoprecipitation pro-
cedure. Previous assays performed in our laboratory showed
no substantial differences in the differentiating effect of
the two concentrations of DETA/NO used. Cells were sub-
sequently cultured in complete medium for an additional
period of 2 days either in the presence or absence of LIF. To
induce differentiation towards definitive endoderm (DE),
cells were preconditioned for 3 days in the absence of LIF and
subsequently exposed to 1mM DETA/NO for 19 hours. Cells
were then maintained in culture medium supplemented with
15% FBS in the absence of LIF for subsequent days. Culture
medium was replaced daily in all experimental conditions.
A D3 line expressing GFP driven by Oct4 promoter
(D3-Oct4 line) was generated by using 4 𝜇g of plasmid
pOct-eGFP, according to a previous publication [28]. Cells
were electroporated (800V, 50𝜇F, 30ms) and selected by
puromycin (Sigma-Aldrich) resistance and GFP expression.
GFP-positive and negative cells were sorted by FACS in
an Advantage SE System (BD FACS Aria Cell Sorter, BD
Biosciences, Erembodegem, Belgium). D3-Oct4 cells were
cultured as above. GFP cell fluorescence was visualized with
an Olympus IX70 inverted microscope.
2.2. RNA Isolation, Reverse Transcription, and Real-Time PCR
Analysis. Total RNA was extracted using TRIzol (Invitrogen,
Paisley, UK) and chloroform/isopropanol purification pro-
cedure. cDNA synthesis was performed with 1𝜇g of total
RNA usingM-MVL reverse transcriptase (Promega, Madrid,
Spain) and random primers according to manufacturer’s
instructions. mRNA levels were measured by real-time PCR
analysis based on SYBR Green (Applied Biosystems, Paisley,
UK) and detection with ABI Prism 7500 (Applied Biosys-
tems). Results were normalized with 𝛽-actin. Real-time PCR
forward (F) and reverse (R) primers used are as follows:
Nanog F: AGCAGATGCAAGAACTCTCCTCCA,
Nanog R: CCGCTTGCACTTCATCCTTTGGTT,
Oct4 F: AGCTGCTGAAGCAGAAGAGGATCA,
Oct4 R: AACACCTTTCCAAAGAGAACGCCC,
Pdx1 F: AGCTCCCTTTCCCGTGGATGAAAT,
Pdx1 R: TAGGCAGTACGGGTCCTCTTGTTT,
FoxA2 F:TCAACGACTGCTTTCTCAAGGTGC,
FoxA2 R: TTCTCGAACATGTTGCCCGAGTCT,
Gata 4 F: AGGGTGAGCCTGTATGTAATGCCT,
Gata 4 R: AGGACCTGCTGGCGTCTTAGATTT,
Cxcr4 F: TGATGCCATGGCTGACTGGTACTT,
Cxcr4 R: AACGCTGCTGTAGAGGTTGACAGT,
Hnf1𝛽 F: ACAGGGCAGAATGTTTGCAACGAG,
Hnf1𝛽 R: TATAGGCATCCATGGCCAGCTTCT,
Sox17 F: TTATGGTGTGGGCCAAAGACGAAC,
Sox17 R: TCAACGCCTTCCAAGACTTGCCTA,
𝛽-actin F: TCCTGTGGCATCCACGAAACTACA,
𝛽-actin R: ACCAGACAGCACTGTGTTGGCATA.
2.3. Protein Extraction and Western Blot. Proteins were
extracted with RIPA buffer (Sigma-Aldrich) supplemented
with a cocktail of protease and phosphatase inhibitors (Sig-
ma-Aldrich). Briefly, cells were trypsinized from culture
dishes, centrifuged, and washed once with cold PBS. Cell
pellets were then resuspended and incubated in RIPA buffer
for 20min on ice and sonicated with 3 pulses 10 sec each
at 10% amplitude (Branson Digital Sonifier, Danbury, CT,
USA). After centrifugation, supernatants were denatured
in Laemmli loading buffer for 10 minutes at 98∘C. Total
protein (20𝜇g) was separated by SDS-PAGE and transferred
to PVDF membranes which were subsequently probed with
anti-Nanog (Bethyl, Montgomery TX, USA), anti-Oct4 (BD
Transduction, San Jose´, CA, USA), anti-Pdx1 (Abcam, Cam-
bridge, UK), anti-Sox17 (Millipore, Billerica, MA, USA), or
anti-Gata4 (SantaCruz Biotechnology,Dallas, TX,USA), and
anti-𝛽-actin (Sigma-Aldrich) as loading control.
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2.4. Immunofluorescence. For confocal studies, cells were
seeded on coverslips as follows. Glass coverslips 24-mm in
diameter were washed in hydrochloric acid and sonicated
in a water bath for 30min. Coverslips were subsequently
rinsed with 50% ethanol and sonicated for 30min. Following
washes with 70% and with 95% ethanol and sonication,
coverslips were air-dried and placed in 6-well tissue culture
plates (Nunc, Rochester, NY, USA). Coating with Matrigel
(BD Biosciences, California, USA) for 2 hours at 37∘C ensues.
Next, coverslips were washed with Knockout Dulbecco’s
modified Eagle’s medium (Gibco) and seeded with D3 cells
at a density of 75 × 103 cells/well. Cells were cultured and
induced to differentiate as above. Then, cells were fixed with
4% paraformaldehyde for 10min, followed by permeabiliza-
tion with methanol (−20∘C) for 5min. Samples were then
exposed to blocking solution for 30min (3% BSA in PBS +
0.1% Tween 20) and incubated overnight at 4∘C with rabbit
anti-Nanog (Bethyl Laboratories,Montgomery, USA),mouse
anti-Gata4 (Santa Cruz Biotechnology), and goat anti-FoxA2
(Santa Cruz Biotechnology). For detection of primary anti-
bodies, anti-mouse Alexa Fluor 488 (Invitrogen, Canada),
anti-rabbit Alexa Fluor 568 (Invitrogen), and anti-goat Alexa
Fluor 488 (Invitrogen) were used. Cells were counterstained
with 300 nM DAPI (Tocris, Bristol, UK). Coverslips were
mounted onmicroscope slides with VECTASHIELDmount-
ing medium (Vector Laboratories, Burlingame, California)
and visualized with a confocal microscope (Leica TCS SP5)
using a HCX PL APO Lambda Blue 100 × 1.4 oil immersion
objective. For quantification, 101 cells with one (Nanog or
Gata4) or two (Nanog andGata4) stains from9different fields
and 116 cells with one (Nanog or FoxA2) or two (Nanog and
FoxA2) stains from 7 different fields from one experiment
were recorded.
2.5. Chromatin ImmunoprecipitationAssay. Batches of 3× 106
cells were cross-linkedwith 1% (w/v) formaldehyde for 10min
at 37∘C.Cellswere then resuspended in lysis buffer containing
10mMTrisHCl (pH 8.0), 10mMNaCl, 3mMMgCl
2
, 0.5mM
DTT, and protease inhibitors for 10min on ice. Following
centrifugation at 4∘C for 5min, supernatants were discarded
and pellets were washed by gentle inversion with 10mM Tris
HCl buffer, pH 8.0 containing 15mM NaCl, and 60mM KCl
and centrifuged for 5min at 4∘C. Pellets were then resus-
pended in washing buffer supplemented with 3mM CaCl
2
,
protease inhibitors, 0.5mM DTT, and 5–10𝜇L of 1 : 200
micrococcal nuclease (New England BioLabs) and incubated
for 20min at 37∘Cwith orbital shaking. Nuclease activity was
halted by addition of 20𝜇L 0.5mM EDTA and preparations
were then centrifuged for 5min at 3000 rpm. Supernatants
were discarded and pellets were resuspended in buffer con-
taining 150mMNaCl, 50mMTrisHCl (pH7.5), 5mMEDTA,
0.5% NP-40, 1% Triton, and 0.01% SDS and sonicated with
3 pulses, 10 s each at 10% amplitude. Sonicates were then
centrifuged for 10min at 10000 rpm at 4∘C, and supernatants
containing chromatin extracts with an average size of 500 bp
were immunoprecipitated with 2–4𝜇g of each specific anti-
body per sample. Anti-acetyl histone H3 (Abcam), anti-
Nanog (Bethyl) were used. Anti-Rabbit IgG (Abcam) was
used as mock ChIP control. Then, 30 𝜇L of blocked Dyn-
abeads (Invitrogen, Dynal AS, Oslo, Norway) were used to
prepare antibody-bead complexes and incubated for 1 h at
4∘C under rotation in dilution buffer (0.01% SDS, 1.1% Triton
X-100, 1.2mM EDTA, 16.7mM Tris HCl (pH 8.1), 167mM
NaCl). Then, chromatin was added and incubated for 1 hour
under the same conditions. Complexes were washed once
with low-salt buffer (0.1% SDS, 1%TritonX-100, 2mMEDTA,
20mM Tris HCl pH 8.1, 150mM NaCl), once with high-salt
buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris
HCl pH 8.1, 500mM NaCl), once with LiCl buffer (0.25M
LiCl, 1% NP40, 1% Deoxycholate, 1mM EDTA, 10mM Tris
HCl, pH 8.0), twice with TE buffer (10mM Tris HCl, pH 8.0,
1mM EDTA) and finally eluted with 500𝜇L solution con-
taining 1% SDS and 0.1M NaHCO
3
. DNA purification was
performed with phenol : chloroform procedure. ChIP analy-
sis was carried out by real time-PCR using SYBR Green. Pro-
moter occupancy was determined by percent input method.
Primers used were as follows:
Nanog promoter F: CCCTAAGCTTTCCCTCCC-
TCC,
Nanog promoter R: CCAAATCAGCCTATCTGA-
AGG,
Brachyury promoter NngBSu F: CCAGAGGTT-
GGCTCCTGGAAA,
Brachyury promoter NngBSu R: GGTGTGGGC-
AGCAGTTGGTTTATT,
BrachP F: TTGCGGGAGTTCAAGTGGAGC,
BrachP R: CTCTCCACCTTCCAGGAGTCTTGA.
2.6. Statistical Analysis. Data shown are expressed as mean ±
SEM of three independent biological replicates unless other-
wise indicated. Student’s 𝑡-test was used. A value of 𝑃 < .05
was accepted as statistically significant.
3. Results
3.1. Nanog and Oct4 Are Reexpressed following NO-Induced
Differentiation. D3 mESCs were cultured for 3 days with or
without LIF and then exposed to 1mM DETA/NO for 19
hours (day 4). A substantial reduction in Nanog and Oct4
protein level was observed in cells following treatment with
DETA/NO (Figure 1(a)). To explore the stability of Nanog
andOct4 downregulation, recovery experimentswere carried
out. After DETA/NO treatment, cells were grown in complete
medium until day 6 in the presence or absence of LIF. The
results show that Nanog and Oct4 proteins were reexpressed
followingDETA/NO exposure. In the case of Nanog, the phe-
nomenon was more apparent in the presence of LIF. A sim-
ilar response was observed in D3 mESCs expressing the
green fluorescence protein (GFP) under the control of the
Oct4 promoter. Cell colonies with homogeneous fluores-
cence were formed when D3 cells were cultured in the
presence of LIF (+LIF/control) (Figure 1(b), GFP Oct4).
Exposure to DETA/NO led to loss of GFP fluorescence in
cells cultured without LIF (Treatment). Similar results were
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Figure 1: Reexpression of pluripotency genes following exposure to DETA/NO. (a) Western blot analysis of Nanog and Oct4 proteins. D3
mESCs were grown in the presence (+LIF) or in the absence (−LIF) of LIF for 3 days. Cells were then cultured as indicated in Section 2 for
additional periods of 1 and 2 days (day 4 and day 5). C: control cells. T: cells exposed to 1mMDETA/NO for 19 h on day 4. Lanes 5 and 6 refer
to cells exposed to DETA/NO and subsequently cultured for 1 and 2 days as in Section 2. (b) GFP expression in D3-Oct4mESCs. Control cells
were cultured in the presence of LIF for 6 days (+LIF/Control). Treated cells were cultured in the presence of 1mMDETA/NO for 19 hours on
day 4 and subsequently cultured as indicated in Section 2 for an additional period of 2 days in absence of LIF. PhC: phase contrast. Results are
representative of 3 independent experiments. (c) Western blot analysis reveals Nanog and Oct4 reexpression after DETA/NO treatment. +/−
LIF indicates that cells were cultured for 4 days in the presence of LIF, then LIF was removed and cells were subsequently exposed to 1mM
DETA/NO for 19 hours. Days 5 and 6 indicate that cells were subsequently cultured for 1 and 2 days in the absence of LIF. −/+LIF indicates
cells that were cultured for 4 days in the absence of LIF; exposure to 1mMDETA/NO for 19 hours was then performed in the presence of LIF.
Days 5 and 6 indicate that cells were subsequently cultured for additional periods of 1 and 2 days, respectively, in the presence of LIF. Results
are representative of 3 independent experiments.
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observed in cells cultured in the presence of LIF (not shown).
Loss of homogeneous colony morphology is also apparent
upon DETA/NO treatment (Figure 1(b), Treatment Ph C).
Heterogeneity in the recovery of GFP signal is apparent
following 2 days of culture in complete medium even in
the absence of LIF (day 6) and up to 4 days (day 8) (see
Supplementary Figure 1 in Supplementary Material available
online at http://dx.doi.org/10.1155/2014/379678) since clusters
of GFP positive cells coexist with GFP negative cells (see PhC
image). In addition, colony morphology is not recovered.
3.2. Nanog and Oct4 Reexpression Is Independent of LIF. In
order to explore the role of LIF on Nanog and Oct4 reex-
pression afterDETA/NOchallenge, experiments were carried
out in which LIF was added or removed to/from cells
preconditioned in the absence or presence of LIF, respectively,
for 3 days. Results show that addition of LIF to media after
NO treatment did not restore completely Nanog and Oct4
protein levels (Figure 1(c), −/+LIF conditions). Nevertheless,
kinetics of Nanog and Oct4 recovery appears to be faster in
cells preconditioned in the presence of LIF before DETA/NO
treatment (Figure 1(c), +/−LIF conditions).Hence, LIF seems
to be dispensable for Nanog and Oct4 reexpression, although
previous exposure to the factor accelerates the process.
3.3. Histone H3 Acetylation Participates in Nanog Reexpres-
sion after NO-Induced Differentiation. Previous reports have
shown that NO induces chromatin reorganizations inmESCs
[25, 27]. Thus, we studied changes in the levels of acetylated
histone occupancy at the Nanog promoter (Figure 2(a)).
Chromatin immunoprecipitation studies show occupancy of
acetylated histone H3 on Nanog promoter in control cells
cultured in the presence of LIF. A significant reduction was
observed in cells cultured in the absence of LIF for the same
period of time (Figure 2(a)). The DETA/NO treatment led
to a strong and significant reduction in occupancy, either in
the absence or presence of LIF. Occupancy is fully recovered
2 days after exposure to DETA/NO. This phenomenon is
more apparent in the presence of LIF. Occupancy at Nanog
promoter by acetylated histone H3 parallels the Nanog
reexpression after DETA/NO treatment both at mRNA
(Figure 2(b)) and protein (Figure 1(a)) in cells cultured with
LIF. The fact that no substantial recovery of Nanog mRNA
levels is observed in cells grown in the absence of LIF
indicates that LIF signaling is required for the expression of
this gene.
In order to study the role of Nanog in differentiating cells,
we analyzed the expression of Brachyury, a reputable mes-
endoderm marker under the control of Nanog. A strong
and significant expression of Brachyury was observed in
cells grown in the absence of LIF when compared with cells
cultured in the presence of LIF. The exposure to DETA/NO
leads to significant decrease in Brachyury expression in LIF-
deprived cells. Brachyury repression is more pronounced 2
days after DETA/NO treatment (Figure 2(c)). Consistently
with its role as repressor, Nanog occupancy at Brachyury
promoter was significantly diminished in cells cultured under
−LIF conditions and the exposure to DETA/NO decreases it
even more (Figure 2(d)). Occupancy was restored to control
levels 2 days after DETA/NO treatment in cells grown in the
presence of LIF and this coincides with Brachyury repression.
DETA/NO treatment led a significant decrease of Nanog
binding to Brachyury promoter in cells grown in the presence
of LIF. A nonsignificant rise in Brachyury mRNA in this
condition suggests that additional factors are involved in
the repression of this gene. Enhanced binding of Nanog at
Brachyury promoter accompanies a strong repression of the
gene after DETA/NO treatment (Figures 2(c) and 2(d)). It
is further observed that changes in the acetylation pattern
at Brachyury promoter participates in the regulation of its
mRNA expression. There is a strong occupancy signal at the
promoter in −LIF condition according to the mRNA expres-
sion. NO treatment induces a decrease on the promoter occu-
pancy consistent with the significant decrease of gene expres-
sion (Supplementary Figure 2). According to the activation
of H3 acetylated, occupancy at the Brachyury promoter is
also observed in +LIFNO condition. This, in concert with
low Nanog occupancy (Figure 2(d)) could account for the
regulation of Brachyury expression.
3.4. Differentiated Cell Populations Express Definitive Endo-
derm Markers in addition to Nanog Reexpression. In order
to assess the impact of Nanog and Oct4 reexpression on the
differentiation process, the expression of definitive endoderm
(DE) markers was analyzed in a defined protocol for gener-
ation of DE cells. Figure 3(a) shows a remarkable downreg-
ulation of Nanog and an increase in Pdx1 expression upon
DETA/NO treatment inmESC. In addition, differentiated cell
populations reexpress Nanog and increase expression of DE
factors such as Gata4 and Sox17 (Figure 3(a)) 1 and 2 days
after NO treatment. Pdx1 expression levels, however, decrease
after NO treatment (Figure 3(a)). To assess the relevance of
Oct4 reexpression on upregulation of DE markers, a mESC
line expressing GFP under the control of Oct4 promoter
was used. Following differentiation, sorted GFP positive and
GFP negative cells were analyzed for expression of Nanog,
Oct4, and different endoderm markers (Figure 3(b)). NO
treatment induces downregulation of Oct4 and Nanog and
upregulation of endoderm markers Gata4, FoxA2, Cxcr4,
and Pdx1 in both GFP negative cells and in residual GFP
positive cells (Figure 3(b), upper and lower left graphs). Only
two days after exposure to differentiating stimulus, both GFP
positive and negative cells upregulate Gata4, FoxA2, Hnf1𝛽,
and Sox17, with significantly higher levels in GFP negative
cell population (Figure 3(b), upper and lower right graphs).
In addition, in order to help understand the differentiation
phase, mesodermal markers Flk1 and Mef2c were analyzed
by quantitative real-time PCR. In the presence of LIF the
expression of both markers decreases following exposure to
DETA/NO, and upregulates after 2 days. On the other hand,
in absence of LIF the treatment induces Flk1 expression and
maintains the increase for 2 days more; nevertheless, Mef2c
also increases its expression after NO but the increase is not
sustained at day 6 (Figure 3(c)).
To test the possibility that the presence of stemness genes
in differentiated cell populations might indeed be ascribed
to cells escaping from differentiation processes, confocal
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Figure 2:Nanog reexpression during differentiation acts as a regulator of cell fate decisions (a) ChIP analysis shows relative levels of acetylated
histone H3 occupancy at Nanog promoter following NO treatment. (b) Real-time PCR analysis of Nanog and (c) Brachyury expression levels
before and after NO treatment. (d) ChIP analysis shows Nanog binding to Brachyury promoter following NO treatment. Histogram plots
represent cells from control, NO treated (day 4), and 2 days after NO treatment (day 6) in the presence (left bars) or absence (right bars)
of LIF, respectively. Data are mean ± SEM from 5 independent biological replicates. ∗Significant difference from undifferentiated control
condition (+LIF).
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Figure 3: Nanog is expressed in differentiated cells. (a) Western blot analysis shows endoderm markers and Nanog reexpression after NO
treatment. Blots are representative of three independent experiments. C: control cells cultured with LIF for 4 days; T: cells cultured with
LIF for 3 days and then exposed to 1mM DETA/NO for 19 h. Days 5 and 6 refer to DETA/NO treated cells cultured in the absence of LIF
for additional periods of 1-2 days. (b) Endoderm markers are expressed in both Oct4 positive and negative cell populations after in vitro
differentiation. Real-time PCR analysis for expression of pluripotent (Oct4 and Nanog) and endoderm (Gata4, FoxA2, Cxcr4, Pdx1, Sox17)
markers in control (undifferentiated cells grown for 4 days in the presence of LIF), treated andDEdifferentiatedGFPpositive andGFPnegative
cells. D3-Oct4 cells were grown, differentiated, and sorted for GFP expression according to the protocol described in Section 2. Control cells
indicate cells grown for 4 days in the presence of LIF; NO-treated cells indicate cells maintained for 3 days in the absence of LIF and treated
for 19 h with 1mM DETA/NO. DE-differentiated cells indicate cells 2 days after treatment in the absence of LIF. ∗Significant difference from
GFP+; ∗∗significantly different from control condition. (c) Quantitative real-time PCR for mesodermal lineage markers expressed before and
after DETA/NO treatment.
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Figure 4: Nanog colocalizes with Gata4 and FoxA2 in definitive endoderm cells. Cells were differentiated according to protocol described in
Section 2 and analysed by confocal immunofluorescence (a) for Nanog, Gata4, and FoxA2 at day 8 of differentiation. (b) Analysis showing
the percentage of cells coexpressing Nanog-Gata4 and Nanog-FoxA2 in D3 differentiated cells. Data are mean ± ESM from 7–9 fields.
microscopy immunofluorescence analyses were performed
in cells induced to differentiate into DE. Nanog expression
increases from 0.65% (data not shown) in NO-treated cells
to 54% in differentiated cells population (data calculated
from Figure 4(a) ratio Nanog + versus Dapi). Results show
that Nanog is heterogeneously expressed inDE-differentiated
cells (Figure 4(a)) and that the majority of Nanog positive
cells also coexpressed Gata4 and FoxA2 (75.4% and 96.2%,
resp.), with the cells expressing only Nanog no more than 7%
(Figures 4(a) and 4(b)).
4. Discussion
The role of genes such asNanog andOct4 in orchestrating the
pluripotent state of ESC is well established. Their potential
role in differentiated states remains, however, to be fully
validated [8–10]. Previous studies have shown that Nanog
downregulates transiently inmESC cultured in homogeneous
conditions in the presence of LIF [8–10]. Fluctuations in
expression levels of Nanog were also described in cells of
the embryo inner mass and in germ cells of developing
embryos [9]. Although the pluripotent state of mESC is
maintained in vitro by LIF in a Nanog dependent manner,
little information is available on the mechanism involved
in the control of its transient expression [1]. We show here
that Nanog reexpression after NO-induced downregulation
is LIF-independent. Interestingly, previous culture of cells in
the presence of LIF for 4 days allows substantial recovery
of Nanog and Oct 4 (+/−LIF condition) when compared
with cells cultured in the absence of LIF (−/+LIF condition)
(Figure 1(c)); thus reexpression is more efficient in cells pre-
viously preconditioned in the presence of LIF. In summary,
the use of LIF in the reexpression experiments shows that
although Nanog and Oct 4 reexpression after NO challenge
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does not require LIF, previous exposure to this factor is
instrumental for this response, thus suggesting that LIF-
dependent factors stabilize the pluripotency network.
Otherwise, after NO treatment Nanog is strongly down-
regulated at the protein and transcript level in the presence
and absence of LIF. However, in the presence of LIF, 2 days
after NO treatment, levels of Nanog transcript are much
higher than expected at the protein level. This phenomenon
makes us think that Nanog epigenetic context is different
depending on LIF presence or absence during pharmacolog-
ical treatments with DETA-NO. Moreover, strong occupancy
of acetylated histoneH3 of theNanog promoter was observed
2 days afterNO treatment both in the presence and absence of
LIF, thus setting the stage for reactivation of this pluripotency
gene. Global epigenetic changes also occur during NO-
induced differentiation and some of these epigenetic mod-
ifications are maintained after withdrawal of the differenti-
ating factor [23]. On the other hand, transient suppression
of Nanog following treatment of mESC with the histone
deacetylase inhibitor TSA (Trichostatin A) has been reported
to be associated with deacetylation of Nanog promoter
region and with start of differentiation [29]. We report here
enhanced occupancy of acetylated histone H3 at Nanog pro-
moter two days after withdrawal of the differentiating stimu-
lus.This phenomenon ismore apparent in the presence of LIF,
coincidentwith strongNanog reactivation.All these data sug-
gest that specific epigenetic modifications of chromatin after
NO-treatments finely regulate in vitro reactivation of Nanog.
The scenario of gene regulation that is proposed here for
mESC differentiation by NO treatment goes through the dis-
ruption ofmesendoderm transition by silencing of Brachyury
and rising the expression of mesoderm and endodermmark-
ers. It has been reported that Brachyury regulation is con-
trolled by histone acetylation at its promoter [30], supporting
our data in which NO treatment induces changes in the
occupancy of H3 acetylated, increasing in the presence of LIF
and decreasing in absence of LIF; this action is suggested to
be complementary with the decrease of the repressive action
ofNanog.This effect on the gene regulation of Brachyury sug-
gests a selective activity ofNO treatment in the differentiation
transition towards mesoderm and endoderm lineages. The
specification of lineage commitment after Nanog and Oct4
downregulation is a matter of debate. Previous reports have
showndifferentiation towards primitive endoderm [8, 31] and
mesoderm [27]. In addition, Nanog null cells do not differ-
entiate solely into primitive endoderm, showingmultilineage
differentiation capacity [9]. To assess the differentiating
capacity and commitment of differentiated cells in our exper-
imental design, beside the expression of endodermal genes,
we analyzed the expression of Brachyury and mesodermal
genes Flk1 and Mef2c. NO treatment led to substantial and
sustained decrease of Brachyury and enhanced expression of
endoderm markers Pdx1, Gata4, and Sox17, reflecting thus
an endoderm selective process, although the upregulation of
Flk1 and Mef2c is evident suggesting also the generation of
mesoderm lineage. In fact, global epigenetic context is differ-
ent before and after NO treatment, creating a differentiating
scenario after NO stimulus with a transient downregulation
of Nanog and a disruption of the mesendodermal transition.
This notion has received support from studies with human
ESCs and with different protocols. In fact, previous studies
from Lie et al. [32] observed that Nanog suppression in
human ESCs causes upregulation of DE genes and effi-
cient differentiation to pancreatic endoderm, confirming our
observations. Nevertheless, Nanog [15] and Oct4 [12, 13] are
expressed in DE progenitors after differentiation with activin
A, reinforcing our observations using NO as a differentiating
agent. Furthermore, it has been reported that pharmaco-
logical blockade of Activin/Nodal signalling pathway during
DE differentiation prevents proper commitment of human
ESCs to the endodermal lineage [14]. Jaremko and Marikawa
showed a reduction in the Oct4 and Nanog expression levels
after 2 days of Nodal/Activin signaling inhibition. Neverthe-
less, Nanog transcripts were reactivated after activin A addi-
tion. In fact, the levels of Oct4 and Nanog transcripts were
not decreased during the first 6 days of DE differentiation in
culture [14], resembling similar results thatwe described here.
In our model of DE differentiation, we selected Oct4 reex-
pressing cells (GFP positive) and analyzed them for expres-
sion of endoderm markers. Both GFP positive and negative
cell populations increase the expression of Gata4, FoxA2, and
Sox17 during differentiation. GFP-negative cell population
hadhigher levels of expression ofDEmarkers, according to its
more differentiated morphology. After NO treatment in LIF
starving conditions, few cells (around 3% of the population)
still express GFP at the protein level, but this is not related to
significant changes in the transcript level of Nanog between
GFP positive and negative cells. However, two days after NO
treatment Nanog transcript is slightly lower in GFP negative
population compared with GFP positive cells in DE-cell
population. This phenomenon can be attributed to different
half-life ratios of GFP-protein andNanog-transcript.The fact
that Nanog and Oct4 are reexpressed heterogeneously after
NO treatment and that Nanog coexpresses with Gata4 and
FoxA2 in cells gives support to the notion that the protocol
used here generates terminally differentiated DE cells.
All in all, the data reported here indicate that pluripo-
tency factors play additional roles other than controlling the
machinery of pluripotency. In fact, Oct4 has a dual role
working with Sox2 to maintain pluripotency and with Sox17
to promote endodermal lineage differentiation [30]. In our
case, environmental perturbations caused by high levels of
NO provoke Nanog and Oct4 downregulation and epige-
netic chromatin modifications, constituting an opportunity
for subsequent differentiation (see Figure 5). Heterogeneous
reexpression of Nanog or Oct4, however, is not a barrier
for DE differentiation, but an inherent property of mESC.
This mechanism might be an evolutionary selected strategy
to respond and adapt to the markedly changing external
environment and for the generation of new progenitors
during differentiation. In fact, during the implantation of
the blastocyst, inducible NO synthase (iNOS) levels increase
markedly in the uterine tissue of rodents [33]. This phe-
nomenon correlates with the transient decrease in Nanog
in newly implanted blastocysts [4, 34]. Subsequently, Nanog
is reexpressed in epiblast cells [35], simulating the schemes
described in this work.Thus, one would expect the relevance
of NO signalling as a new biological system regulating
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Figure 5: Model for stem cell differentiation. During ES cell differentiation, Nanog and Oct4 expression is downregulated and nascent
epigenetic modifications occur. At this point, nitric oxide can participate in transient downregulation of pluripotency network and also
in chromatin remodelling events. Nevertheless, Nanog can be reexpressed in transient differentiated precursors. By this, fluctuating levels
of Nanog and Oct4 constitute an “opportunity” for commitment through specific lineage differentiation. Nitric oxide participates in this
perturbation, but further intrinsic or environmental stimuli are needed for correct commitment decision.
the pluripotency in embryonic cells, setting the stage for the
development of new strategies for regenerative medicine.
5. Conclusions
Nitric oxide has been used as a differentiator agent in both
mouse and human ESCs. The process involves transient
downregulation of master genes of pluripotency such as
Nanog and Oct4. The present paper shows that Nanog reex-
pression after NO-induced differentiation involves epigenetic
changes on Nanog promoter. Recruitment of Nanog on
Brachyury promoter blocks the reactivation of this mesendo-
dermal marker. Definitive endoderm differentiated cells
coexpress endoderm markers and Nanog and the expression
of mesodermal genes is also apparent. It is thus proposed
that reexpression of Nanog and Oct4 plays a role in the
differentiation towards specific cell lineages.
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